Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Digeril Reflux
- Development stage
- Unknown
- Lead developer
- Farmayala Pharmaceutical Company
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Digeril Reflux is an antacid and antiflatulent combination medication developed and marketed by Farmayala Pharmaceutical Company. It is composed of two active ingredients: magaldrate (800 mg), a magnesium aluminate hydrate complex, and simethicone (40-60 mg). Magaldrate acts as a non-systemic antacid by neutralizing gastric acid and maintaining a stomach pH between 3 and 5, which provides relief from heartburn and acid reflux. Simethicone is an anti-foaming agent that acts as a surfactant to reduce the surface tension of gas bubbles in the gastrointestinal tract, facilitating their coalescence and expulsion to alleviate bloating and abdominal distension. The drug is manufactured by INDEUREC S.A. in Ecuador and is available in multiple formulations, including chewable tablets and oral suspensions.
- Brand names
- DigerilDigeril Reflux
- Other names
- magaldrate + simethicone
Beyond the preview
Go deeper on Digeril Reflux.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Digeril Reflux.